Clough Capital Partners L P Takes Position in Oscar Health, Inc. $OSCR

Clough Capital Partners L P bought a new position in Oscar Health, Inc. (NYSE:OSCR) during the 3rd quarter, Holdings Channel.com reports. The fund bought 44,454 shares of the company’s stock, valued at approximately $842,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Farther Finance Advisors LLC grew its stake in Oscar Health by 4,420.7% during the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after acquiring an additional 1,282 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio bought a new position in shares of Oscar Health during the 1st quarter valued at about $30,000. Tsfg LLC bought a new position in shares of Oscar Health during the 3rd quarter valued at about $38,000. Finally, EMC Capital Management purchased a new position in shares of Oscar Health during the second quarter valued at about $64,000. Institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a research report on Thursday, February 12th. Stephens assumed coverage on Oscar Health in a report on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price target for the company. Piper Sandler raised Oscar Health from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $13.00 to $25.00 in a research note on Tuesday, November 25th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research report on Thursday, January 22nd. Finally, UBS Group reissued a “neutral” rating and issued a $15.00 target price on shares of Oscar Health in a report on Wednesday, February 11th. Two investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $16.88.

Oscar Health Trading Up 1.7%

Shares of OSCR stock opened at $13.22 on Friday. The company has a market cap of $3.93 billion, a PE ratio of -7.59 and a beta of 1.91. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.80. The stock’s 50 day simple moving average is $14.53 and its two-hundred day simple moving average is $16.47. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.96 and a quick ratio of 0.96.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). The company had revenue of $2.81 billion during the quarter, compared to analysts’ expectations of $3.12 billion. Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.Oscar Health’s revenue for the quarter was up 17.3% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.62) EPS. Research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 23,038 shares of Oscar Health stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total transaction of $406,620.70. Following the completion of the transaction, the insider directly owned 350,180 shares of the company’s stock, valued at $6,180,677. The trade was a 6.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 138,835 shares of company stock valued at $2,298,269 in the last ninety days. 24.39% of the stock is owned by company insiders.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.